Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
PAVM
PAVM News & Events
-
Add to Watchlist
Trade PAVM
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
PAVM News
PAVmed Secures $30 Million in Series D Preferred Stock Offering
4 days ago
PRnewswire
PAVmed Subsidiary Secures VA Contract for EsoGuard Test, Expanding Access to Over 9 Million Veterans
Jan 22 2026
Benzinga
Lucid Diagnostics Secures VA Contract for EsoGuard, Boosting PAVmed Stock by 291%
Jan 21 2026
Benzinga
PAVmed Subsidiary Wins VA Contract for Esophageal Precancer Testing, Shares Surge 250%
Jan 21 2026
stocktwits
Netflix, Inc. (NFLX) Reports Q4 Earnings Beat but Issues Lower Q1 Guidance, Shares Down 3%
Jan 21 2026
Benzinga
Lucid Diagnostics (LUCD) Secures VA Contract for EsoGuard Esophageal DNA Test at Medicare Pricing
Jan 21 2026
seekingalpha
Lucid Diagnostics Secures VA Contract for EsoGuard Test, Expanding Access to 9 Million Veterans
Jan 21 2026
Newsfilter
PAVmed Executes 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing
Dec 30 2025
PRnewswire
Show More News
PAVM Events
02/02 09:50
PAVmed Trading Resumes
PAVmed trading resumes
02/02 09:40
PAVmed Trading Halted Due to Volatility
PAVmed trading halted, volatility trading pause
01/21 09:50
PAVmed Trading Resumes
PAVmed trading resumes
01/21 09:40
PAVmed Trading Halted Due to Volatility
PAVmed trading halted, volatility trading pause
Show More Events
PAVM Monitor News
PAVmed Raises $30 Million to Strengthen Financial Position
Feb 06 2026
PAVmed Inc. surges as it crosses above 5-day SMA
Feb 02 2026
PAVmed's Subsidiary Wins VA Contract, Stock Surges
Jan 26 2026
PAVmed's Subsidiary Secures VA Contract, Stock Drops 17.49%
Jan 23 2026
PAVmed Inc. stock rises amid technical breakout
Jan 21 2026
PAVM Earnings Analysis
No Data
People Also Watch